When will Oxford AstraZeneca COVID-19 vaccine trial in India resume? Here’s what Serum Institute says
[ad_1] The Serum Institute of India said, “Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials.” [ad_2] Source link